New study aims to unlock secrets of liver cancer to build better treatments

NCT ID NCT04145141

First seen Nov 01, 2025 · Last updated May 17, 2026 · Updated 28 times

Summary

This study is collecting blood, urine, stool, and tissue samples from 132 adults with liver cancer who have had or plan to have immunotherapy. The goal is to build a large biobank of samples and health data to help researchers understand how liver cancer develops and responds to treatment. Participants are followed for life by phone or email, but no new treatments are given as part of this study.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIVER CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Memorial Sloan Kettering Cancer Center

    New York, New York, 10065, United States

  • National Institutes of Health Clinical Center

    Bethesda, Maryland, 20892, United States

  • Thomas Jefferson University

    Philadelphia, Pennsylvania, 19107, United States

  • University of Texas Southwestern Medical Center

    Dallas, Texas, 75390, United States

Conditions

Explore the condition pages connected to this study.